Skip to main content

Marizyme

  • About
      • Back
      • Overview
      • Executive Management
      • Board of Directors
      • Corporate Governance
  • Products
      • Back
      • Overview
      • DuraGraft®
      • Krillase®
      • MATLOC™ Platform
  • Clinical
      • Back
      • Publications
      • DuraGraft Publications
      • MATLOC Publications
  • Investors
  • Contact
      • Back
      • Contact Us
  • Sign Up
  • Language
      • Back
      • GER
adobe stock 229690447 preview

NEWS
2021

  • 2023
  • 2022
  • 2021
List of articles in category 2021
Title
03.12.2021
Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories

03.12.2021
Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congress

16.11.2021
Marizyme is Pleased to Announce the Appointment of David Barthel as CEO

04.03.2021
Marizyme Announces New Distribution and Channel Partnership for Chilean Market with Abdera

04.02.2021
Marizyme, Inc. Appoints Veteran Business Executive Julie Kampf to Board

01.02.2021
Marizyme, Inc. Strengthens Senior Management Team with Two Appointments: Roger Schaller EVP, Commercial Operations and Amy Chandler, EVP, Regulatory Affairs and Quality Management Systems

14.01.2021
Marizyme Announces Approval for DuraGraft® in India

11.01.2021
Marizyme Announces the Use of DuraGraft® as the Standard-of-Care in Patients Undergoing Coronary Artery Bypass Surgery (CABG) at Vienna Heart Center North Floridsdorf

07.01.2021
Marizyme, Inc. to Present at Biotech Showcase 2021 During the J.P. Morgan Healthcare Conference Biotech Showcase Digital, BIO @ JPM During "J.P. Morgan Week 2021"

imgfooter

Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health outcomes.

 

Investors

  • Back
  • Stock Info
  • SEC Filings
  • Corporate Governance

Contact

  • Back
  • Contact Us
  • Sign Up
 
 

Get In Touch 

noun map 223137 555 Heritage Drive, Ste. 205,
Jupiter, FL 33458
noun phone 4637987 (561) 935-9955
noun email 3083073 info@marizyme.com 
Marizyme
© Copyright - 2023 Marizyme Inc. | All Rights Reserved | Website by Sandman Media Inc